Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia

Blood. 2003 Apr 15;101(8):3049-51. doi: 10.1182/blood-2002-05-1448. Epub 2002 Dec 27.

Abstract

Heparin-induced thrombocytopenia (HIT) is a transient antibody-mediated hypercoagulability state strongly associated with lower-limb deep-vein thrombosis (DVT). Whether HIT is additionally associated with upper-limb DVT--either with or without central venous catheter (CVC) use--is unknown. We therefore studied 260 patients with antibody-positive HIT to determine the influence of CVC use on frequency and localization of upper-extremity DVT in comparison with 2 non-HIT control populations (postoperative orthopedic surgery and intensive-care unit patients). Compared with the control populations, both upper- and lower-extremity DVTs were found to be associated with HIT. Upper-extremity DVTs occurred more frequently in HIT patients with a CVC (14 of 145 [9.7%]) versus none of 115 (0%) patients without a CVC (P =.000 35). All upper-extremity DVTs occurred at the CVC site (right, 12; left, 2; kappa = 1.0; P =.011). We conclude that a localizing vascular injury (CVC use) and a systemic hypercoagulability disorder (HIT) interact to explain upper-extremity DVT complicating HIT.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Arm / blood supply
  • Autoimmune Diseases / chemically induced*
  • Autoimmune Diseases / complications
  • Case-Control Studies
  • Catheterization, Central Venous* / adverse effects
  • Heparin / adverse effects*
  • Heparin / immunology
  • Humans
  • Ontario / epidemiology
  • Postoperative Complications / etiology
  • Retrospective Studies
  • Risk
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / complications
  • Venous Thrombosis / epidemiology
  • Venous Thrombosis / etiology*

Substances

  • Heparin